Page 438 - Binder2

• Cold-chain infrastructure that spans continents to
preserve molecular stability.
• Insurance systems built to verify, delay, deny, and
authorize.

It is a model that assumes fragility—of the product, of the
patient, of the system itself.

But edible biologics invite us to flip that script.

Because if the molecule:

• Can be taken orally,
• Stored at room temperature,
• Produced locally in a plant-based system,
• And tolerized by the immune system instead of
provoking it...

…then we no longer have to contort human lives to fit
pharmaceutical pathways.
We can build delivery systems that fit people—not the
other way around.

Not a Shortcut—A Better Route

Skeptics may scoff.
They may call edible biologics less serious, less potent,
less mature.

But that critique reveals a deep misunderstanding.

This is not about convenience for its own sake.
It’s about access as a feature, not an afterthought.

436